Dr. Tracy Cole joins n-Lorem Foundation with expertise in all aspects and stages of drug discovery and development. Most recently at Neurocrine Biosciences, Tracy led internal preclinical efforts to advance AAV gene therapy-based drug discovery. Prior to joining Neurocrine, Tracy was an integral part of Ionis Pharmaceutical’s neuroscience group where she coordinated with clinical, pharmacokinetic, toxicology, in vitro screening, regulatory, legal, and translational medicine groups to bring multiple ASO therapies to the clinic.
Tracy received her Ph.D. in neurobiology and behavior at the University of California, Irvine, where she focused on the involvement of inflammation in Alzheimer’s disease, specifically one aspect of the innate immune response called the complement cascade. Tracy has contributed to nine clinical development compound patents and authored/co-authored over ten top-tier journal publications.